Skip to main content
. 2022 Apr 16;107(7):e2680–e2689. doi: 10.1210/clinem/dgac217

Figure 3.

Figure 3.

Average insulin-like growth factor-1 (IGF-1) SD score (SDS) over 104 weeks for heiGHt subjects. Average IGF-1 SDS over 104 weeks for patients who were treated with lonapegsomatropin (green line, triangles) or daily somatropin (blue line, circles) in the heiGHt trial and were treated with lonapegsomatropin in the enliGHten trial (orange lines, triangles or circles).